{"id":8369,"date":"2008-08-14T00:00:00","date_gmt":"2008-08-14T00:00:00","guid":{"rendered":""},"modified":"-0001-11-30T00:00:00","modified_gmt":"-0001-11-30T04:00:00","slug":"index-eyes-bargains-in-biotech","status":"publish","type":"post","link":"https:\/\/hedgeco.net\/news\/08\/2008\/index-eyes-bargains-in-biotech.html","title":{"rendered":"Index eyes bargains in biotech"},"content":{"rendered":"<p>Reuters UK &#8211; Bombed-out valuations present an unprecedented buying opportunity in the European biotech sector, according to venture capital firm Index Ventures, which is eyeing both early and late-stage opportunities.       <\/p>\n<p>&quot;It&#8217;s like being in a candy shop,&quot; partner Francesco De Rubertis told Reuters. &quot;I&#8217;m very optimistic about the fact that a year from now, or a year and a half from now, the market will be very high.&quot;<\/p>\n<p>He sees a major disconnect in current pricing for biotech assets, with Big Pharma companies regularly paying 50 to 100 percent takeover premiums for businesses that have been shunned by risk-averse investors.<\/p>\n<p>Europe is a particularly fertile ground because of its relative immaturity.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" height=\"1\" border=\"0\" width=\"1\" src=\"http:\/\/feeds.feedburner.com\/~r\/reuters\/UKFundsNews\/~4\/363876757\" \/><br \/>  <strong><a target=\"_blank\" href=\"http:\/\/www.hedgeco.net\/news\/news_land.php?i=http:\/\/feeds.feedburner.com\/~r\/reuters\/UKFundsNews\/~3\/363876757\/idUKARO34665220080813\">Read Complete Article<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Reuters UK &#8211; Bombed-out valuations present an unprecedented buying opportunity in the European biotech sector, according to venture capital firm Index Ventures, which is eyeing both early and late-stage opportunities. &quot;It&#8217;s like being in a candy shop,&quot; partner Francesco De [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[1024,408,2135,117,129,83,1258],"class_list":["post-8369","post","type-post","status-publish","format-standard","hentry","category-syndicated","tag-1-million","tag-attractiveness","tag-general-partner","tag-investment-arm","tag-losses","tag-medallion","tag-remorse"],"_links":{"self":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/8369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/comments?post=8369"}],"version-history":[{"count":0,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/8369\/revisions"}],"wp:attachment":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media?parent=8369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/categories?post=8369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/tags?post=8369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}